首页 | 本学科首页   官方微博 | 高级检索  
     

神农心脑康胶囊的研制及临床应用
引用本文:张晓春,蒋从清,张振建. 神农心脑康胶囊的研制及临床应用[J]. 中国医院药学杂志, 2003, 23(6): 337-338
作者姓名:张晓春  蒋从清  张振建
作者单位:随州市中心医院,湖北,随州,441300
摘    要:目的:研究神农心脑康胶囊的制备和质量标准,观察临床治疗冠心病心绞痛的治疗效果。方法:用薄层色谱鉴别麝香、银杏、川芎、淫羊藿的成分,单盲临床观察40例冠心病心绞痛的患者并确定其临床治疗冠心病心绞痛的疗效标准。结果:薄层扫描法可用于鉴别其主药;经临床观察冠心病心绞痛患者,其总有效率达87.5%。结论:制备工艺合理,所得制剂质量可控,治疗冠心病心绞痛疗效显著,且无任何不良反应。

关 键 词:神农心脑康胶囊 薄层扫描法 冠心病 临床疗效
文章编号:1001-5213(2003)06-0337-02
修稿时间:2002-04-10

Preparation and clinical application of Shennong Xinnao Kang capsules
ZHANG Xiao-Chun,JIANG Cong-Qin,ZHANG Zheng-Jian. Preparation and clinical application of Shennong Xinnao Kang capsules[J]. Chinese Journal of Hospital Pharmacy, 2003, 23(6): 337-338
Authors:ZHANG Xiao-Chun  JIANG Cong-Qin  ZHANG Zheng-Jian
Abstract:OBJECTIVE To study the preparation and quality standard of Shennong Xinnao Kang capsule, and observe its effect on treating coronary heart disease with angina pectoris. METHODS A thin layer chromatography was used to identify the main components of the capsule. Study on coronary heart disease with angina pectoris was only blindly assigned and the criteria of therapeutic efficacy were established. RESULTS The thin layer chromatography of the main drugs was reliable.The total symptomatic effective rate of coronary heart disease with angina pectoris was 87.5%.CONCLUSIONS The quality of the capsule can be properly controlled.
Keywords:Shennong Xinnao Kang capulse  thin layer chromatography  coronary heart disease  clinical effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号